Business Context and Reporting Period
Company: BioCardia, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 8, 2026
Reporting Period: The filing reports on a specific event occurring on June 5, 2026, and announced on June 8, 2026.
Key Financial Metrics
This filing does not contain comprehensive financial statements (revenue, profit, cash flow, or margins). It reports a specific capital raising event:
- Shares Sold: 3,509,604 shares of Common Stock.
- Average Price: $1.279 per share.
- Total Proceeds: Approximately $4.49 million (calculated as 3,509,604 shares × $1.279).
- Transaction Type: "At The Market" offering pursuant to an agreement with H.C. Wainwright & Co.
Debt and Liquidity: The filing text does not provide specific values for total debt, cash balances, or liquidity ratios.
Material Changes
The material change reported is the issuance of new equity shares. This transaction increases the company's outstanding share count and cash position. No comparative period data is provided in this specific 8-K filing to quantify changes in operating metrics versus prior periods.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) but does not include the text of the commentary within the body of the 8-K. The transaction was executed under an existing "At The Market" offering agreement.
Risks and Contingencies: The filing explicitly states that the information in Item 8.01 and Exhibit 99.1 is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, meaning it is not subject to the same liabilities as filed documents nor incorporated by reference unless specifically cited elsewhere.
Investor Verification Checklist
- Verify the exact total gross proceeds and any associated underwriting discounts or commissions in the attached press release (Exhibit 99.1).
- Confirm the updated total number of shares outstanding following this issuance.
- Review the remaining capacity under the "At The Market" offering agreement with H.C. Wainwright & Co.
- Check subsequent filings (e.g., 10-Q or 10-K) for the impact of these proceeds on the company's cash position and burn rate.